Parkwood LLC’s Bristol-Myers Squibb BMY Stock Holding History

Parkwood LLC’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-8,142	Closed	-$423K	–	198
2014 Q1	$423K	Sell	8,142 -443	-5%	-$23.6K	0.1%	90
2013 Q4	$456K	Buy	+8,585	New	+$437K	0.11%	81

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Parkwood LLC's BMY Position: Q2 2014 in Review

Parkwood LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 8,142 shares — an estimated $423K sold.

Parkwood LLC first reported a position in BMY in Q4 2013 and held it in 2 quarters. The position peaked at $456K in Q4 2013. 1,302 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

Parkwood LLC reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
Parkwood LLC sold 8,142 Bristol-Myers Squibb shares in Q2 2014, an estimated $423K.
Parkwood LLC first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 2 quarters.
Parkwood LLC's Bristol-Myers Squibb position peaked at $456K in Q4 2013.
1,302 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Parkwood LLC's 13F filing for Q2 2014, filed 1 Aug 2014.